B1S.F YSB Inc.
- Market cap
- EUR 239M
- P/E
- 11.7x
- P/B
- 0.75x
- ROE
- 6.3%
- Dividend yield
- 4.00%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is B1S.F undervalued?
Graham numberB1S.F trades 37.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
YSB Inc. fundamental analysis
No fundamental analysis for YSB Inc. yet.
YSB Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About YSB Inc.
YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eL…
Full company profileYSB Inc. financial statements
YSB Inc. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 10.1B | 14.3B | 17.0B | 17.9B | 21.0B |
| Gross Profit | 914M | 1.43B | 1.74B | 1.81B | 2.31B |
| Operating Income | -401M | -236M | -48.9M | -83.6M | 69.5M |
| EBITDA | - | -1.35B | -3.07B | 154M | 302M |
| Net Income | -502M | -1.50B | -3.21B | 30.0M | 153M |
| EPS | -0.79 | -2.37 | -5.01 | 0.04 | 0.23 |
| Balance Sheet | |||||
| Total Assets | 3.44B | 4.11B | 5.21B | 6.50B | 7.56B |
| Total Liabilities | 6.35B | 8.48B | 3.33B | 4.23B | 5.18B |
| Shareholders' Equity | -2.90B | -4.35B | 1.92B | 2.32B | 2.44B |
| Cash & Short-term Investments | 384M | 835M | 674M | 1.01B | 707M |
| Cash Flow | |||||
| Operating Cash Flow | -487M | 98.2M | 451M | 656M | 638M |
| Capital Expenditure | 121M | 43.7M | 17.5M | 23.4M | 18.2M |
| Free Cash Flow | -608M | 54.5M | 434M | 632M | 619M |
| Ratios | |||||
| ROE | - | - | -167.0% | 1.3% | 6.3% |
| ROA | -14.6% | -36.5% | -61.5% | 0.5% | 2.0% |
| Net Profit Margin | -5.0% | -10.5% | -18.9% | 0.2% | 0.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
YSB Inc. dividends
- Dividend yield
- 4.00%
- Forward dividend
- 0.01 EUR
- Payout ratio
- 33.2%
- Ex-dividend date
- May 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 50.8M | 0.07 | 33.2% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns YSB Inc.
- Insiders 39.16%
- Institutions 7.78%
- Public & others 53.06%
- Shares outstanding 684M
- Free float 322M
YSB Inc. company profile
- Company name
- YSB Inc.
- Ticker
- B1S.F
- ISIN
- KYG9879S1003
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Employees
- 6,795
- Fiscal year end
- December
- Address
- Yaoshibang Building, Guangzhou, China
- Phone
- 86 40 0118 0958
- Website
- ysbang.cn
About YSB Inc.
YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. In addition, the company engages in the wholesale and retail of pharmaceutical and healthcare products. Further, it provides medical testing services; logistics services; and ClouDiagnos. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.
YSB Inc. management
5- Mr. Buzhen ZhangCEO & Executive Chairman · born 1975
- Mr. Fei ChenCFO, Executive Director & Joint Company Secretary · born 1984
- Mr. Zhuoqi ChenChief Technology Officer · born 1979
- Ms. Wai Sum Fung A.C.I.S., A.C.S.Joint Company Secretary · born 1983
- Mr. Haodong XiaoVice President · born 1973